| Shoko Emily Abe, MD | |
|
3100 San Pablo Ave Ste 430, Berkeley, CA 94702-2498 | |
| (415) 476-3358 | |
| (510) 985-5202 |
| Full Name | Shoko Emily Abe |
|---|---|
| Gender | Female |
| Speciality | General Surgery |
| Experience | 18 Years |
| Location | 3100 San Pablo Ave Ste 430, Berkeley, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609178136 | NPI | - | NPPES |
| 1609178136 | Medicaid | NC | |
| 1609178136 | Medicaid | IA | |
| 47053395014 | Medicaid | NE |
| Facility Name | Location | Facility Type |
|---|---|---|
| Alta Bates Summit Medical Center | Oakland, CA | Hospital |
| Ucsf Medical Center | San francisco, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ucsf Dept Of Surgery | 7719886373 | 156 |
News Archive
All across the country, state legislatures and governors are grappling with bills designed to limit access to abortion or contraception. In Virginia, it's affecting a U.S. Senate race.
Swedish studies show that mice that receive a supplement of the "appetite hormone" ghrelin increase their sexual activity. Whether the hormone has the same impact on humans is unknown - but if it does, the researchers may have found the key to future treatments for sex abuse.
Even as states like California push the health law exchanges, bolstered by a growing list of celebrity pitchmen, surveys of some groups - among them, physician practices and likely Virginia voters - show continued doubts about the marketplaces.
Sophia Genetics, the global leader in Data-Driven Medicine (DDM), announced today the signing of a new strategic partnership with Integrated DNA Technologies (IDT).
TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells for severe chronic inflammatory and autoimmune diseases, announces today that the United States Food and Drug Administration has accepted TxCell's Investigational New Drug application for the company's lead product, Ovasave(R), currently in a phase 2b clinical trial for the treatment of patients with refractory Crohn's disease.
› Verified 5 days ago
| Entity Name | University Of California San Francisco |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861578973 PECOS PAC ID: 4486567229 Enrollment ID: O20031212000897 |
News Archive
All across the country, state legislatures and governors are grappling with bills designed to limit access to abortion or contraception. In Virginia, it's affecting a U.S. Senate race.
Swedish studies show that mice that receive a supplement of the "appetite hormone" ghrelin increase their sexual activity. Whether the hormone has the same impact on humans is unknown - but if it does, the researchers may have found the key to future treatments for sex abuse.
Even as states like California push the health law exchanges, bolstered by a growing list of celebrity pitchmen, surveys of some groups - among them, physician practices and likely Virginia voters - show continued doubts about the marketplaces.
Sophia Genetics, the global leader in Data-Driven Medicine (DDM), announced today the signing of a new strategic partnership with Integrated DNA Technologies (IDT).
TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells for severe chronic inflammatory and autoimmune diseases, announces today that the United States Food and Drug Administration has accepted TxCell's Investigational New Drug application for the company's lead product, Ovasave(R), currently in a phase 2b clinical trial for the treatment of patients with refractory Crohn's disease.
› Verified 5 days ago
| Entity Name | Ucsf Dept Of Surgery |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477627537 PECOS PAC ID: 7719886373 Enrollment ID: O20040102000839 |
News Archive
All across the country, state legislatures and governors are grappling with bills designed to limit access to abortion or contraception. In Virginia, it's affecting a U.S. Senate race.
Swedish studies show that mice that receive a supplement of the "appetite hormone" ghrelin increase their sexual activity. Whether the hormone has the same impact on humans is unknown - but if it does, the researchers may have found the key to future treatments for sex abuse.
Even as states like California push the health law exchanges, bolstered by a growing list of celebrity pitchmen, surveys of some groups - among them, physician practices and likely Virginia voters - show continued doubts about the marketplaces.
Sophia Genetics, the global leader in Data-Driven Medicine (DDM), announced today the signing of a new strategic partnership with Integrated DNA Technologies (IDT).
TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells for severe chronic inflammatory and autoimmune diseases, announces today that the United States Food and Drug Administration has accepted TxCell's Investigational New Drug application for the company's lead product, Ovasave(R), currently in a phase 2b clinical trial for the treatment of patients with refractory Crohn's disease.
› Verified 5 days ago
| Entity Name | Ucsf Medical Group Business Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477624104 PECOS PAC ID: 3779497870 Enrollment ID: O20040622001513 |
News Archive
All across the country, state legislatures and governors are grappling with bills designed to limit access to abortion or contraception. In Virginia, it's affecting a U.S. Senate race.
Swedish studies show that mice that receive a supplement of the "appetite hormone" ghrelin increase their sexual activity. Whether the hormone has the same impact on humans is unknown - but if it does, the researchers may have found the key to future treatments for sex abuse.
Even as states like California push the health law exchanges, bolstered by a growing list of celebrity pitchmen, surveys of some groups - among them, physician practices and likely Virginia voters - show continued doubts about the marketplaces.
Sophia Genetics, the global leader in Data-Driven Medicine (DDM), announced today the signing of a new strategic partnership with Integrated DNA Technologies (IDT).
TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells for severe chronic inflammatory and autoimmune diseases, announces today that the United States Food and Drug Administration has accepted TxCell's Investigational New Drug application for the company's lead product, Ovasave(R), currently in a phase 2b clinical trial for the treatment of patients with refractory Crohn's disease.
› Verified 5 days ago
| Entity Name | Epic Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780107797 PECOS PAC ID: 5890053094 Enrollment ID: O20171215002809 |
News Archive
All across the country, state legislatures and governors are grappling with bills designed to limit access to abortion or contraception. In Virginia, it's affecting a U.S. Senate race.
Swedish studies show that mice that receive a supplement of the "appetite hormone" ghrelin increase their sexual activity. Whether the hormone has the same impact on humans is unknown - but if it does, the researchers may have found the key to future treatments for sex abuse.
Even as states like California push the health law exchanges, bolstered by a growing list of celebrity pitchmen, surveys of some groups - among them, physician practices and likely Virginia voters - show continued doubts about the marketplaces.
Sophia Genetics, the global leader in Data-Driven Medicine (DDM), announced today the signing of a new strategic partnership with Integrated DNA Technologies (IDT).
TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells for severe chronic inflammatory and autoimmune diseases, announces today that the United States Food and Drug Administration has accepted TxCell's Investigational New Drug application for the company's lead product, Ovasave(R), currently in a phase 2b clinical trial for the treatment of patients with refractory Crohn's disease.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shoko Emily Abe, MD 3100 San Pablo Ave Ste 430, Berkeley, CA 94702-2498 Ph: (415) 476-3358 | Shoko Emily Abe, MD 3100 San Pablo Ave Ste 430, Berkeley, CA 94702-2498 Ph: (415) 476-3358 |
News Archive
All across the country, state legislatures and governors are grappling with bills designed to limit access to abortion or contraception. In Virginia, it's affecting a U.S. Senate race.
Swedish studies show that mice that receive a supplement of the "appetite hormone" ghrelin increase their sexual activity. Whether the hormone has the same impact on humans is unknown - but if it does, the researchers may have found the key to future treatments for sex abuse.
Even as states like California push the health law exchanges, bolstered by a growing list of celebrity pitchmen, surveys of some groups - among them, physician practices and likely Virginia voters - show continued doubts about the marketplaces.
Sophia Genetics, the global leader in Data-Driven Medicine (DDM), announced today the signing of a new strategic partnership with Integrated DNA Technologies (IDT).
TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells for severe chronic inflammatory and autoimmune diseases, announces today that the United States Food and Drug Administration has accepted TxCell's Investigational New Drug application for the company's lead product, Ovasave(R), currently in a phase 2b clinical trial for the treatment of patients with refractory Crohn's disease.
› Verified 5 days ago
Bruce James Rice, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 2316 Dwight Way, Berkeley, CA 94704 Phone: 510-845-4500 Fax: 510-845-0360 | |
Frederick Wright, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2999 Regent St, Suite 622, Berkeley, CA 94705 Phone: 510-883-9292 | |
Dr. Calvin Boyd Benton, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 3031 Telegraph Ave, Suite 217, Berkeley, CA 94705 Phone: 510-981-8222 Fax: 510-568-8848 | |
Rita Ophelia Kwan-feinberg, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2850 Telegraph Ave, Suite 120, Berkeley, CA 94705 Phone: 510-204-8120 | |
Kieran Melody, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2704 8th St, Berkeley, CA 94710 Phone: 510-381-4542 | |
Jeffrey Stern, Surgery Medicare: May Accept Medicare Assignments Practice Location: 2001 Dwight Way, 2nd Floor, Berkeley, CA 94704 Phone: 510-204-5745 Fax: 510-504-5749 | |
Kristine A. Steensma, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 2793 Benvenue Ave, Berkeley, CA 94705 Phone: 510-843-6735 |